EUVIMEDOdkrijte EUVIMED
Beobachtungsstudie

Improved Utilization Rate in Solid Organ Donors ≥80 Years: The 7‐Year Tuscany Experience

Chiara Lazzeri iD, Davide Ghinolfi, Lara Entani Santini, Arianna Precisi O Procissi, Daniele Cultrera, Adriano Peris

Clinical Transplantation · 2025

DOI: 10.1111/ctr.70142 ↗

At a glance

Beobachtungsstudie in Clinical Transplantation, 2025. Written by Chiara Lazzeri and 5 co-authors. Institution: Regional Transplant Center, Cleveland, USA. Major MEDLINE topics: Tissue Donors, Tissue and Organ Procurement, COVID-19, Organ Transplantation. 27 references.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Introduction

The Tuscany Region has a quite high annual number of donors per million population (100 donors/pmp (annually)). Considering the increasing donor age and organ shortage, the donation and transplantation community needs to expand procurement and transplants from elderly donors. We assessed the utilization rate in donors aged ≥80 years during the study period (2018–2024) in Tuscany.

Methods

Our retrospective observational study comprised 809 donors aged ≥80 years. We compared Period 1 (from 2018 to 2020, before the COVID pandemic) to Period 2 (from 2021 to 2024, after the COVID pandemic). Results cDCD donors significantly increased in Period 2 (0.0001). The utilization rate increased from Period 1 to Period 2 (81.5% vs. 91.7%). In the study period (2018–2024), 377 liver transplants were performed. Overall graft and patient survival at 1, 3, and 5 years when an octogenarian graft was used was 89.4%, 85.0%, 81.8% and 92.5%, 88.7%, 85.5%, respectively. EAD (early allograft dysfunction) was observed in 2.9% of the cases, and IC (ischemic cholangiopathy) developed in 6.3% of the cases. Forty kidneys were transplanted into 22 patients, including 18 dual kidney transplants.

Conclusions

During the 7‐year study period, donors aged ≥80 years represented a consistent subgroup, since they accounted for one‐third of the overall donor population. The increase in utilization rate observed during the study period may be related to several factors, both in the procurement and the transplant phase. Trial Registration : Clinicaltrial.gov: #NCT04744389

Subjects

MeSH terms (MEDLINE)

Tissue DonorsTissue and Organ ProcurementCOVID-19Organ TransplantationHumansRetrospective StudiesMaleFemaleAged, 80 and overItalyFollow-Up StudiesGraft SurvivalPrognosisSurvival RateSARS-CoV-2

Author keywords

brain death donorsdonation after circulatory deatholder donorsutilization rate

Authors and institutions

  • Regional Transplant Center, Cleveland, USA.
  • Division of Hepatic Surgery and Liver Transplantation, Pisa, Italy.
  • Coordinamento Area Vasta Sud Est, Azienda USL Toscana Sudest, Grosseto, Italy.
  • Coordinamento Area Vasta Nord Ovest, Pisa, Italy.
  • Coordinamento AV Centro, Firenze, Italy.

ORCID profiles: Chiara Lazzeri

Cite

APA

Lazzeri, C., Ghinolfi, D., Santini, L. E., Procissi, A. P. O., Cultrera, D., & Peris, A. (2025). Improved Utilization Rate in Solid Organ Donors ≥80 Years: The 7‐Year Tuscany Experience. Clinical Transplantation. https://doi.org/10.1111/ctr.70142

Vancouver

Lazzeri C, Ghinolfi D, Santini LE, Procissi APO, Cultrera D, Peris A. Improved Utilization Rate in Solid Organ Donors ≥80 Years: The 7‐Year Tuscany Experience. Clinical Transplantation. 2025. doi:10.1111/ctr.70142

BibTeX
@article{Lazzeri2025,
  author = {Lazzeri, Chiara and Ghinolfi, Davide and Santini, Lara Entani and Procissi, Arianna Precisi O and Cultrera, Daniele and Peris, Adriano},
  title = {Improved Utilization Rate in Solid Organ Donors ≥80 Years: The 7‐Year Tuscany Experience},
  journal = {Clinical Transplantation},
  year = {2025},
  doi = {10.1111/ctr.70142}
}
Start for free →